Bristol-Myers Squibb Co. and three subsidiaries of Sanofi say the potential for a big payday motivated the state of Texas to ...

Asundexian's Phase 3 study results raise hopes for a new class of cardiovascular drugs that has seen clinical setbacks.

German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a ...

Texas Attorney General Ken Paxton claims that for decades the drugmakers failed to disclose that the medication is less ...

Texas sues Sanofi and Bristol-Myers Squibb over alleged Plavix failures, as Paxton also finalizes a $41.5 million settlement ...

Texas Attorney General Ken Paxton filed a lawsuit Thursday on behalf of the state that takes aim at “false, misleading, and ...

Four Danish patients who experienced vision loss after using Novo Nordisk's Wegovy and Ozempic were awarded compensation ...

Dear Dr. Roach: I am struggling with a decision process due to a lack of consensus among various physicians. I was fortunate ...

Texas Attorney General Ken Paxton sued Bristol Myers Squibb and Sanofi on Thursday, accusing the drugmakers of failing to ...

McKool Smith and The Lanier Law Firm, along with Texas Attorney General Ken Paxton, have filed a lawsuit on behalf of the State of Texas against pharmaceutical giants Bristol-Myers Squibb Company and ...

The Lanier Law Firm is serving as outside legal counsel for the State of Texas and Attorney General Ken Paxton in a lawsuit against pharmaceutical giants Bristol-Myers Squibb Company and several ...

Major medical study reveals clopidogrel prevents heart attacks 14% better than aspirin with no extra bleeding risk.